is a privately-held biotech company from Dresden offering partnerships and solutions for better drug discovery with Dynamic DNA-Encoded Library (D-DEL) technologies. We have overhauled the DEL discovery process by introducing proprietary innovations in library design, selection and validation, all of which lead to a faster path to high-quality, relevant starting points for medicinal chemistry – and the only DEL platform on the market fully designed to integrate with a fragment-based discovery methodology.


DyNAbind GmbH
Tatzberg 47
01307 Dresden



Copyright © 2020 DyNAbind GmbH | Concept and implementation by kasamedia.